Short Bowel Syndrome clinical trials at UCSF
2 in progress, 1 open to new patients

• Registry for Participants With Short Bowel Syndrome

  open to all eligible people

  This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for participants with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in participants with SBS. SBS participants treated and not treated with teduglutide will be enrolled.

  San Francisco, California and other locations

• Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

  Sorry, in progress, not accepting new patients

  This study will follow participants who completed the TED-C14-006 study. The purpose of this study is to evaluate the long-term safety and efficacy of teduglutide in pediatric participants with Short Bowel Syndrome (SBS). This study will also offer teduglutide treatment to eligible participants, regardless of treatment received in TED-C14-006 or SHP633-301.

  San Francisco, California and other locations

Last updated: August 14, 2018